MoonLake Immunotherapeutics (MLTX) Sector Health Care
(Current)
$56.20 1.31 (2.39%)
Open Price: 55.75
MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company unlocking the potential of Sonelokimab, the novel investigational Nanobody® for the treatment of inflammation, to revolutionize outcomes for patients